Filing Details
- Accession Number:
- 0001110803-14-000303
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-09-03 20:10:56
- Reporting Period:
- 2014-09-02
- Filing Date:
- 2014-09-03
- Accepted Time:
- 2014-09-03 20:10:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1008891 | Blaine A Bowman | 5200 Illumina Way San Diego CA 92122 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-09-02 | 5,000 | $19.61 | 17,722 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-09-02 | 4,008 | $179.59 | 13,714 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-09-02 | 992 | $179.99 | 12,722 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-09-02 | 5,000 | $0.00 | 5,000 | $19.61 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
24,456 | 2008-01-26 | 2017-01-26 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 670 | Indirect | by Partnership |
Common Stock | 198 | Indirect | by Trust |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 4,008 shares sold ranging from $178.93 to $179.90 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 992 shares sold ranging from $179.94 to $180.10 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.